Krystal Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.About KRYS
Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK.
CEOKrish S. Krishnan
CEOKrish S. Krishnan
Employees275
Employees275
HeadquartersPittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded2016
Founded2016
Employees275
Employees275
KRYS Key Statistics
Market cap6.43B
Market cap6.43B
Price-Earnings ratio32.62
Price-Earnings ratio32.62
Dividend yield—
Dividend yield—
Average volume249.06K
Average volume249.06K
High today$222.66
High today$222.66
Low today$213.83
Low today$213.83
Open price$215.80
Open price$215.80
Volume400.30K
Volume400.30K
52 Week high$222.66
52 Week high$222.66
52 Week low$122.80
52 Week low$122.80
Stock Snapshot
Krystal Biotech(KRYS) stock is priced at $221.96, giving the company a market capitalization of 6.43B. It carries a P/E multiple of 32.62.
On 2025-12-04, Krystal Biotech(KRYS) stock traded between a low of $213.83 and a high of $222.66. Shares are currently priced at $221.96, which is +3.8% above the low and -0.3% below the high.
The Krystal Biotech(KRYS)'s current trading volume is 400.3K, compared to an average daily volume of 249.06K.
During the past year, Krystal Biotech(KRYS) stock moved between $122.80 at its lowest and $222.66 at its peak.
During the past year, Krystal Biotech(KRYS) stock moved between $122.80 at its lowest and $222.66 at its peak.
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%
People also own
Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.